
Jon E. Angell
Examiner (ID: 3741, Phone: (571)272-0756 , Office: P/1674 )
| Most Active Art Unit | 1635 |
| Art Unit(s) | 1635, 1637, 1674 |
| Total Applications | 1431 |
| Issued Applications | 721 |
| Pending Applications | 199 |
| Abandoned Applications | 530 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6576555
[patent_doc_number] => 20100129491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'Tryptophan transporter gene and use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/991162
[patent_app_country] => US
[patent_app_date] => 2006-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7942
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20100129491.pdf
[firstpage_image] =>[orig_patent_app_number] => 11991162
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/991162 | Tryptophan transporter gene and use thereof | Aug 30, 2006 | Abandoned |
Array
(
[id] => 4485692
[patent_doc_number] => 07902352
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-08
[patent_title] => 'Isolated nucleic acid duplex for reducing huntington gene expression'
[patent_app_type] => utility
[patent_app_number] => 11/501634
[patent_app_country] => US
[patent_app_date] => 2006-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 32
[patent_no_of_words] => 14653
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/902/07902352.pdf
[firstpage_image] =>[orig_patent_app_number] => 11501634
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/501634 | Isolated nucleic acid duplex for reducing huntington gene expression | Aug 8, 2006 | Issued |
Array
(
[id] => 4485692
[patent_doc_number] => 07902352
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-08
[patent_title] => 'Isolated nucleic acid duplex for reducing huntington gene expression'
[patent_app_type] => utility
[patent_app_number] => 11/501634
[patent_app_country] => US
[patent_app_date] => 2006-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 32
[patent_no_of_words] => 14653
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/902/07902352.pdf
[firstpage_image] =>[orig_patent_app_number] => 11501634
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/501634 | Isolated nucleic acid duplex for reducing huntington gene expression | Aug 8, 2006 | Issued |
Array
(
[id] => 8017315
[patent_doc_number] => 08138160
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-20
[patent_title] => 'Reagents, methods and systems to suppress pro-inflammatory cytokines'
[patent_app_type] => utility
[patent_app_number] => 11/498649
[patent_app_country] => US
[patent_app_date] => 2006-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6850
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/138/08138160.pdf
[firstpage_image] =>[orig_patent_app_number] => 11498649
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/498649 | Reagents, methods and systems to suppress pro-inflammatory cytokines | Aug 2, 2006 | Issued |
Array
(
[id] => 6623282
[patent_doc_number] => 20100003753
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-07
[patent_title] => 'Multivalent rna nanoparticles for delivery of active agents to a cell'
[patent_app_type] => utility
[patent_app_number] => 11/989590
[patent_app_country] => US
[patent_app_date] => 2006-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 66
[patent_figures_cnt] => 66
[patent_no_of_words] => 48729
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20100003753.pdf
[firstpage_image] =>[orig_patent_app_number] => 11989590
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/989590 | Multivalent rna nanoparticles for delivery of active agents to a cell | Jul 31, 2006 | Abandoned |
Array
(
[id] => 4971226
[patent_doc_number] => 20070111228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-17
[patent_title] => 'RNA interference'
[patent_app_type] => utility
[patent_app_number] => 11/496966
[patent_app_country] => US
[patent_app_date] => 2006-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 62
[patent_figures_cnt] => 62
[patent_no_of_words] => 30767
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20070111228.pdf
[firstpage_image] =>[orig_patent_app_number] => 11496966
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/496966 | RNA interference | Jul 30, 2006 | Abandoned |
Array
(
[id] => 5204955
[patent_doc_number] => 20070026436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-01
[patent_title] => 'GLUCOSE TRANSPORT-RELATED GENES, POLYPEPTIDES, AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 11/460102
[patent_app_country] => US
[patent_app_date] => 2006-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16155
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20070026436.pdf
[firstpage_image] =>[orig_patent_app_number] => 11460102
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/460102 | GLUCOSE TRANSPORT-RELATED GENES, POLYPEPTIDES, AND METHODS OF USE THEREOF | Jul 25, 2006 | Abandoned |
Array
(
[id] => 4899812
[patent_doc_number] => 20080119426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-22
[patent_title] => 'Compositions and methods for the treatment of muscle wasting'
[patent_app_type] => utility
[patent_app_number] => 11/479112
[patent_app_country] => US
[patent_app_date] => 2006-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 22879
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20080119426.pdf
[firstpage_image] =>[orig_patent_app_number] => 11479112
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/479112 | Compositions and methods for the treatment of muscle wasting | Jun 29, 2006 | Issued |
Array
(
[id] => 5928963
[patent_doc_number] => 20110038922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'COMPOUNDS FOR TREATING OR PREVENTING AMINE OXIDASE RELATED DISEASES OR DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 11/917638
[patent_app_country] => US
[patent_app_date] => 2006-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5329
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20110038922.pdf
[firstpage_image] =>[orig_patent_app_number] => 11917638
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/917638 | COMPOUNDS FOR TREATING OR PREVENTING AMINE OXIDASE RELATED DISEASES OR DISORDERS | Jun 11, 2006 | Abandoned |
Array
(
[id] => 5391187
[patent_doc_number] => 20090208500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-20
[patent_title] => 'Method of producing antibodies with improved function'
[patent_app_type] => utility
[patent_app_number] => 11/447506
[patent_app_country] => US
[patent_app_date] => 2006-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 34714
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20090208500.pdf
[firstpage_image] =>[orig_patent_app_number] => 11447506
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/447506 | Method of producing antibodies with improved function | Jun 4, 2006 | Abandoned |
Array
(
[id] => 4820310
[patent_doc_number] => 20080226601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'Herpes Virus-Based Compositions and Methods of Use in the Prenatal and Perinatal Periods'
[patent_app_type] => utility
[patent_app_number] => 11/916434
[patent_app_country] => US
[patent_app_date] => 2006-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 33411
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20080226601.pdf
[firstpage_image] =>[orig_patent_app_number] => 11916434
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/916434 | Herpes Virus-Based Compositions and Methods of Use in the Prenatal and Perinatal Periods | Jun 4, 2006 | Abandoned |
Array
(
[id] => 12509910
[patent_doc_number] => 10000757
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-19
[patent_title] => Gene vector
[patent_app_type] => utility
[patent_app_number] => 11/921140
[patent_app_country] => US
[patent_app_date] => 2006-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 9
[patent_no_of_words] => 22787
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11921140
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/921140 | Gene vector | May 25, 2006 | Issued |
Array
(
[id] => 5141393
[patent_doc_number] => 20070003609
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => 'Vectorization of dsRNA by cationic particles and topical use'
[patent_app_type] => utility
[patent_app_number] => 11/436515
[patent_app_country] => US
[patent_app_date] => 2006-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13181
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20070003609.pdf
[firstpage_image] =>[orig_patent_app_number] => 11436515
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/436515 | Vectorization of dsRNA by cationic particles and topical use | May 18, 2006 | Issued |
Array
(
[id] => 10056290
[patent_doc_number] => 09095630
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-04
[patent_title] => 'Vectorization of dsRNA by cationic particles and use of same on a skin model'
[patent_app_type] => utility
[patent_app_number] => 11/436775
[patent_app_country] => US
[patent_app_date] => 2006-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 11
[patent_no_of_words] => 13860
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11436775
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/436775 | Vectorization of dsRNA by cationic particles and use of same on a skin model | May 18, 2006 | Issued |
Array
(
[id] => 6597829
[patent_doc_number] => 20100048678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'Nucleic acids and polypeptides that are useful in controlling neuronal regeneration'
[patent_app_type] => utility
[patent_app_number] => 11/920721
[patent_app_country] => US
[patent_app_date] => 2006-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22360
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20100048678.pdf
[firstpage_image] =>[orig_patent_app_number] => 11920721
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/920721 | Nucleic acids and polypeptides that are useful in controlling neuronal regeneration | May 17, 2006 | Abandoned |
Array
(
[id] => 5480033
[patent_doc_number] => 20090202990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'METHODS FOR THE SELECTION OF APTAMERS'
[patent_app_type] => utility
[patent_app_number] => 11/916776
[patent_app_country] => US
[patent_app_date] => 2006-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 10991
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20090202990.pdf
[firstpage_image] =>[orig_patent_app_number] => 11916776
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/916776 | Methods for the selection of aptamers | May 15, 2006 | Issued |
Array
(
[id] => 5220277
[patent_doc_number] => 20070161588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-12
[patent_title] => 'Modulating cancer cell characteristics'
[patent_app_type] => utility
[patent_app_number] => 11/436962
[patent_app_country] => US
[patent_app_date] => 2006-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 3782
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20070161588.pdf
[firstpage_image] =>[orig_patent_app_number] => 11436962
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/436962 | Modulating cancer cell characteristics | May 15, 2006 | Issued |
Array
(
[id] => 5046540
[patent_doc_number] => 20070265214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-15
[patent_title] => 'Antisense antiviral agent and method for treating ssRNA viral infection'
[patent_app_type] => utility
[patent_app_number] => 11/431968
[patent_app_country] => US
[patent_app_date] => 2006-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15369
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0265/20070265214.pdf
[firstpage_image] =>[orig_patent_app_number] => 11431968
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/431968 | Antisense antiviral agent and method for treating ssRNA viral infection | May 9, 2006 | Issued |
Array
(
[id] => 5732795
[patent_doc_number] => 20060257912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Methods and sequences to suppress primate huntington gene expression'
[patent_app_type] => utility
[patent_app_number] => 11/429491
[patent_app_country] => US
[patent_app_date] => 2006-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 13804
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20060257912.pdf
[firstpage_image] =>[orig_patent_app_number] => 11429491
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/429491 | Methods and sequences to suppress primate huntington gene expression | May 3, 2006 | Abandoned |
Array
(
[id] => 5242159
[patent_doc_number] => 20070020652
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-25
[patent_title] => 'Methods and compositions for RNA interference'
[patent_app_type] => utility
[patent_app_number] => 11/413795
[patent_app_country] => US
[patent_app_date] => 2006-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 20298
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20070020652.pdf
[firstpage_image] =>[orig_patent_app_number] => 11413795
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/413795 | Methods and compositions for RNA interference | Apr 27, 2006 | Abandoned |